You have 2 free disease views remaining today. Register for more view, it is 100% free →
progressive myoclonus epilepsy 3
Description
Progressive Myoclonus Epilepsy (PME) Description
Progressive myoclonus epilepsy, also known as Lafora disease, is a rare brain disorder characterized by recurrent seizures (epilepsy) and a decline in intellectual function. The signs and symptoms of the disorder usually appear in late childhood or adolescence and worsen with time.
Key Features:
- Recurrent seizures (epilepsy)
- Decline in intellectual function
- Symptoms typically appear in late childhood or adolescence
- Worsening symptoms over time
This condition is a type of progressive myoclonus epilepsy, which is a group of rare genetic disorders that affect the central nervous system. The exact cause and inheritance pattern of Lafora disease are not fully understood.
References:
[3] Description of the disorder usually appears in late childhood or adolescence and worsen with time. [4] The recent history of PMEs begins in 1989 with a consensus statement published in the wake of the Marseille PME workshop. ... Lafora disease is an autosomal recessive progressive myoclonus epilepsy and ... [13] Progressive myoclonus epilepsies were classically defined as progressive disorders presenting primarily with the association of epileptic generalized tonic-clonic seizures and multifocal ...
Additional Characteristics
- Recurrent seizures (epilepsy)
- Decline in intellectual function
- Symptoms typically appear in late childhood or adolescence
- Worsening symptoms over time
Signs and Symptoms
Early Signs and Symptoms of Progressive Myoclonus Epilepsy
Progressive myoclonus epilepsy, also known as Unverricht-Hoffmann disease, is a rare genetic disorder that affects the nervous system. The early
Additional Symptoms
- epilepsy
- myoclonus
Diagnostic Tests
Diagnostic Tests for Progressive Myoclonus Epilepsy
Progressive myoclonus epilepsy (PME) can be diagnosed through a combination of clinical findings and diagnostic tests.
- Electroencephalogram (EEG): An EEG is a non-invasive test that records the electrical activity of the brain. It can help diagnose PME by showing characteristic patterns of electrical activity, such as generalized spike-and-wave discharges [3].
- Molecular genetic testing: Genetic testing can be used to identify specific genes associated with different types of PME, such as EPM1, EPM2A, and others [2]. This test is particularly useful for diagnosing Lafora disease and other forms of PME.
- Electromyography (EMG): An EMG measures the electrical activity of muscles. It can be used to diagnose myoclonic jerks and other muscle-related symptoms associated with PME [7].
- Imaging studies: Imaging studies, such as MRI or CT scans, may be used to rule out other conditions that could be causing similar symptoms.
It's worth noting that the diagnosis of PME is often made based on a combination of clinical findings, EEG results, and genetic testing. A team of specialists, including neurologists and genetic counselors, may work together to diagnose and manage this condition [1].
References:
[1] Epilepsy centers provide you with a team of specialists to help you diagnose your epilepsy and develop a treatment plan.
[2] Genetic testing can be used to identify specific genes associated with different types of PME.
[3] An EEG is a non-invasive test that records the electrical activity of the brain, which can help diagnose PME.
[7] An EMG measures the electrical activity of muscles and can be used to diagnose myoclonic jerks and other muscle-related symptoms associated with PME.
Treatment
Treatment Options for Progressive Myoclonus Epilepsy
The treatment of progressive myoclonus epilepsy (PME) primarily focuses on managing symptoms, as there is no current cure for the condition. According to various studies and medical sources [1][2], anticonvulsant drugs are commonly used to control seizures in PME patients.
Commonly Prescribed Medications
Some of the most frequently prescribed medications for PME include:
- Clonazepam: A benzodiazepine that can help reduce seizure frequency and severity [3].
- Divalproex: An anticonvulsant medication that has been shown to be effective in suppressing seizures in some patients with PME [4].
- Primidone: Another anticonvulsant drug that may be used to manage seizures in individuals with PME [5].
Important Considerations
When initiating treatment, it's essential to start with low doses and gradually increase as needed. Additionally, patients taking divalproex chronically should have their diets supplemented with carnitine to prevent potential side effects [6].
Differential Diagnosis
Differential Diagnoses for Progressive Myoclonus Epilepsy
Progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature both myoclonus and seizures that worsen gradually over a variable timeframe. When considering differential diagnoses, it's essential to rule out other conditions that may present with similar symptoms.
Dravet Syndrome: One condition that should be considered in the differential diagnosis is Dravet syndrome, which typically presents in the first year of life. This rare genetic disorder is characterized by severe seizures and developmental delays. If not treated appropriately, it can mimic the progressive myoclonus epilepsies with worsening epilepsy.
Juvenile Myoclonic Epilepsy: Another condition that may be considered in the differential diagnosis is juvenile myoclonic epilepsy (JME). JME can present with similar symptoms to PME, including myoclonus and generalized seizures. However, it's essential to note that JME typically presents later in childhood or adolescence.
Other Conditions: Other conditions that should be considered in the differential diagnosis of PME include:
- Classic late-infantile form of NCL: This rare genetic disorder can present with similar symptoms to PME, including myoclonus and seizures.
- Opsoclonus-myoclonus syndrome: This rare neurological disorder can also present with similar symptoms to PME.
Key Points
- Differential diagnosis for PME is not always easy and requires careful consideration of age at onset and concomitant signs and symptoms associated with myoclonic epilepsy. [6]
- Each form of progressive myoclonus epilepsy has distinct characteristics that can help differentiate it from other conditions. [12]
References
[3] - Juvenile myoclonic epilepsy may mimic the progressive myoclonus epilepsies with worsening epilepsy if not treated appropriately. [6] - Differential diagnosis for PME is not always easy and requires careful consideration of age at onset and concomitant signs and symptoms associated with myoclonic epilepsy. [12] - Each form of progressive myoclonus epilepsy has distinct characteristics that can help differentiate it from other conditions.
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_5767
- owl#annotatedSource
- t379511
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0111446
- core#notation
- DOID:0111446
- oboInOwl#hasDbXref
- UMLS_CUI:C2673257
- IAO_0000115
- A progressive myoclonus epilepsy characterized by onset of intractable myoclonic seizures before age 2 years and developmental regression that has_material_basis_in homozygous or compound heterozygous mutation in the KCTD7 gene on chromosome 7q11.21.
- oboInOwl#hasExactSynonym
- Progressive myoclonus epilepsy type 3
- rdf-schema#label
- progressive myoclonus epilepsy 3
- rdf-schema#subClassOf
- t379919
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.